Fidelity National Information Services (FIS)
49.70
+0.44 (0.89%)
NYSE · Last Trade: Mar 15th, 2:44 AM EDT
IonQ and D-Wave Quantum are two of the top investment options in the industry.
Via The Motley Fool · March 13, 2026
Broadridge Financial Solutions has underperformed its sector peers recently, yet analysts remain moderately optimistic about the stock’s prospects.
Via Barchart.com · March 13, 2026

The Schwab U.S. Dividend Equity ETF (SCHD) emphasizes durable dividend payers with strong financial health, while the Fidelity High Dividend ETF (FDVV) mixes dividend income with exposure to large growth companies. Understanding how these strategies differ can help investors decide whether their dividend allocation should prioritize income stability or participation in market-leading stocks.
Via The Motley Fool · March 13, 2026
Today’s Date: March 13, 2026 Introduction As of March 2026, the global technology landscape has undergone a paradigm shift, transitioning from the experimental phase of Generative AI to a period of industrial-scale deployment. Standing at the epicenter of this transformation is Broadcom Inc. (NASDAQ: AVGO), a company that has evolved from a diversified chipmaker into [...]
Via Finterra · March 13, 2026
The quantum computing powerhouse has already lost over 60% of its peak value, but more downside could be on the way.
Via The Motley Fool · March 13, 2026

Identical yields mask key differences in sector exposure and risk, making portfolio fit a crucial factor for income-focused investors.
Via The Motley Fool · March 12, 2026

Expense ratios, sector tilts, and portfolio concentration set these two dividend ETFs apart for income-focused investors.
Via The Motley Fool · March 12, 2026
Via Benzinga · March 12, 2026
Date: March 12, 2026 Introduction Dianthus Therapeutics (NASDAQ: DNTH) has become the center of Wall Street’s attention today, with its share price surging 19.4% in early trading following a pivotal update from its Phase 3 CAPTIVATE trial. The company, which specializes in "next-generation" complement inhibitors, announced that its lead candidate, claseprubart (DNTH103), met early responder [...]
Via Finterra · March 12, 2026
Date: March 12, 2026Sector: Biotechnology / NeurologyMarket Cap: ~$4.8 Billion Introduction On March 9, 2026, the neurology sector of the biotechnology market witnessed a seismic shift. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) released long-awaited Phase 3 results for its lead candidate, azetukalner (formerly XEN1101), sending its stock price soaring by 46.5%. The X-TOLE2 trial, which evaluated [...]
Via Finterra · March 12, 2026
Via Benzinga · March 12, 2026
Via Benzinga · March 11, 2026
IonQ's growth is poised to accelerate nicely thanks to the cost and performance advantages of its quantum computing systems.
Via The Motley Fool · March 11, 2026
IonQ is one of the most promising quantum computing stocks.
Via The Motley Fool · March 11, 2026
The U.S. Treasury market has entered a period of extraordinary turbulence as of March 10, 2026, with the benchmark 10-year yield completing a "wild ride" that saw it briefly touch 3.96%. This significant decline from January’s highs of 4.26% was initially sparked by a flight-to-safety as
Via MarketMinute · March 10, 2026
Date: March 10, 2026 Introduction As of March 2026, Coinbase Global, Inc. (NASDAQ: COIN) has transcended its origins as a mere cryptocurrency exchange to become the primary infrastructure layer for the global on-chain economy. Long dismissed by skeptics as a "crypto casino," the company has spent the last five years methodically building a moat that [...]
Via Finterra · March 10, 2026
FIS has underperformed the broader Technology sector over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.
Via Barchart.com · March 10, 2026
The quantum computing company is trailing its competitors when it comes to its systems' accuracy.
Via The Motley Fool · March 10, 2026

According to a report by The Guardian, the Bank Policy Institute, which represents JPMorgan Chase, Goldman Sachs, Citigroup, and other big banks, is planning to sue the OCC.
Via Stocktwits · March 10, 2026
There's no right amount to save for retirement, but most Americans now think they need more than ever, given the high cost of living.
Via The Motley Fool · March 9, 2026
As of March 9, 2026, Marvell Technology, Inc. (Nasdaq: MRVL) has transitioned from a cyclical provider of storage controllers to a structural cornerstone of the global artificial intelligence (AI) infrastructure. Often described by analysts as the "architect of the AI interconnect," Marvell has spent the last decade positioning itself at the intersection of high-speed data [...]
Via Finterra · March 9, 2026
Over the past six months, Fidelity National Financial’s stock price fell to $49.21. Shareholders have lost 17.9% of their capital, which is disappointing con...
Via StockStory · March 9, 2026
As expected, net worth improves with age. There's one obviously important high-growth time of life, though.
Via The Motley Fool · March 8, 2026
IonQ and D-Wave look like two of the best pure-play quantum computing companies.
Via The Motley Fool · March 7, 2026
Here are three key things to note about the average Canadian's RRSP balance at age 55, and what to do with this information.
Via The Motley Fool · March 7, 2026